VCYT, Veracyte, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for VCYT

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask VCYT by Subscribing to iPick.ai Premium!



Stock Chart



Competitors:

(CRIS) Curis, Inc


Latest YouTube Video:

Please Login/Register (click on the top-right button) to see the latest video on VCYT, Veracyte, Inc.

CEO:Mr. Marc A. Stapley

Headquarter: 6000 Shoreline Court, Suite 300, South San Francisco, CA, United States, 94080

Industry: Biotechnology,   Employees: 824

Business Summary

Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It is also developing the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.